‘Text/HTML’ of page ‘NRG-GU008: INNOVATE Study for Prostate Cancer’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-GU008: INNOVATE Study for Prostate Cancer
‘Text/HTML’ of page ‘NRG-GU008: INNOVATE Study for Prostate Cancer’
Am I eligible for this study? If you over the age of 18 with prostate cancer that has spread to your lymph nodes, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor […]
Read More‘Text/HTML’ of page ‘NRG-GU008: INNOVATE Study for Prostate Cancer’
About This Study NRG-GU008, also known as the “INNOVATE” study, is a clinical study for patients who have node-positive prostate cancer and need more treatment after prostatectomy. This trial compares the usual treatment of hormone therapy and radiation therapy, to apalutamide added to the usual treatment. The addition of apalutamide to the usual treatment […]
Read More‘Text/HTML’ of page ‘NRG-GU008: INNOVATE Study for Prostate Cancer’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-GU008: INNOVATE Study for Prostate Cancer’
INNOVATE STUDY FAQ
Read More